Skip to main content

April 30th, 2021 – Birmingham, Michigan – CitySide Ventures and Birmingham Angels announces adding IndividuALLytics to its portfolio of companies.

Birmingham Angels, a CitySide’s Angels Capital Network, just joined a partial seed round investment in IndividuALLytics.

We are very excited to announce the addition of IndividuALLytics as another portfolio company. Digital health is one of the most rapidly growing healthcare market segments on a global basis.  We believe that IndividuALLytics is potentially on track to become the leader and medical standard of care for the 58 Million USA patients [CMS] and several hundred million global MCC citizens [WHO] who are coping with multiple chronic conditions (MCC).

Individuals who are diagnosed with multiple chronic medical conditions (MCC) are often the most difficult for doctors to provide care. Treatments for one condition can complicate, even undermine, treatments and outcomes for the other condition. 58 Million US and several hundred million global citizens are coping with MCC. US MCC patients are 70% of overall health care expenditures at $2.7 Tril. per year growing 3% to 6% per year, which is unsustainable.

This particular funding round goal is to help them demonstrate their SasS business model of sharing digital data (a 1,000 patient study) on a more ongoing basis back and forth with patients and physicians will improve patient outcomes and save money for providers and patients.”  – David Weaver – Chief Investment Officer at CitySide Ventures

Birmingham Angels’ goal is to become a premier Investment group committed to taking Michigan Angel investing to a new level by building a network of active, progressive, and innovative investors committed to turning Michigan into a powerhouse startup ecosystem.

For more information about Birmingham Angels please visit us at

If you are an accredited investor and would like to schedule a private meeting,
please complete the following request form:

or contact us:; 248. 535.1306


Our Gold Sponsors!